These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12944120)

  • 1. Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element.
    Hoogendijk CF; Scholtz CL; Pimstone SM; Ehrenborg E; Kastelein JJ; Defesche JC; Thiart R; du Plessis L; de Villiers JN; Zaahl MG; Delport R; Rubinsztein DC; Raffel LJ; Grim CE; Mediene-Benchekor S; Amouyel P; Brousseau T; Steyn K; Lombard CJ; Hayden MR; Kotze MJ
    Mol Cell Probes; 2003 Aug; 17(4):175-81. PubMed ID: 12944120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.
    Thiart R; Scholtz CL; Vergotine J; Hoogendijk CF; de Villiers JN; Nissen H; Brusgaard K; Gaffney D; Hoffs MS; Vermaak WJ; Kotze MJ
    J Med Genet; 2000 Jul; 37(7):514-9. PubMed ID: 10882754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemia.
    Scholtz CL; Peeters AV; Hoogendijk CF; Thiart R; de Villiers JN; Hillermann R; Liu J; Marais AD; Kotze MJ
    Hum Mol Genet; 1999 Oct; 8(11):2025-30. PubMed ID: 10484771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase gene.
    Ehrenborg E; Clee SM; Pimstone SN; Reymer PW; Benlian P; Hoogendijk CF; Davis HJ; Bissada N; Miao L; Gagné SE; Greenberg LJ; Henry R; Henderson H; Ordovas JM; Schaefer EJ; Kastelein JJ; Kotze MJ; Hayden MR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2672-8. PubMed ID: 9409241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent LDL-receptor mutation causes familial hypercholesterolaemia in South African coloureds and Afrikaners.
    Kotze MJ; Langenhoven E; Theart L; Loubser O; Micklem A; Oosthuizen CJ
    S Afr Med J; 1995 May; 85(5):357-61. PubMed ID: 7638684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners.
    Kotze MJ; Langenhoven E; Warnich L; du Plessis L; Retief AE
    Ann Hum Genet; 1991 May; 55(2):115-21. PubMed ID: 1952806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects.
    Leren TP; Solberg K; Røsby O; Rødningen OK; Tonstad S; Ose L; Berg K
    Clin Genet; 1992 Nov; 42(5):224-8. PubMed ID: 1486698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
    Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-allelic polymorphic system in exon 12 of the LDL receptor gene is highly informative for segregation analysis of familial hypercholesterolemia in the Spanish population.
    Puig O; Chaves FJ; García-Sogo M; Real J; Gil JV; Armengod ME
    Clin Genet; 1996 Jul; 50(1):50-3. PubMed ID: 8891387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.
    Lee WK; Haddad L; Macleod MJ; Dorrance AM; Wilson DJ; Gaffney D; Dominiczak MH; Packard CJ; Day IN; Humphries SE; Dominiczak AF
    J Med Genet; 1998 Jul; 35(7):573-8. PubMed ID: 9678702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.
    Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Inoue T; Mori M; Tada H; Nakanishi C; Yagi K; Yamagishi M; Ueda K; Takegoshi T; Miyamoto S; Inazu A; Koizumi J;
    Atherosclerosis; 2014 Sep; 236(1):54-61. PubMed ID: 25014035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-basepair deletion in repeat 1 of the LDL receptor promoter reduces transcriptional activity in a South African Pedi.
    Peeters AV; Kotze MJ; Scholtz CL; De Waal LF; Rubinsztein DC; Coetzee GA; Zuliani G; Streiff R; Liu J; van der Westhuyzen DR
    J Lipid Res; 1998 May; 39(5):1021-4. PubMed ID: 9610768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An LDL receptor promoter mutation in a heterozygous FH patient with dramatically skewed ratio between the two allelic mRNA variants.
    Jensen LG; Jensen HK; Nissen H; Kristiansen K; Faergeman O; Bolund L; Gregersen N
    Hum Mutat; 1996; 7(1):82-4. PubMed ID: 8664911
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
    Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
    J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia.
    Dedoussis GV; Pitsavos C; Kelberman D; Skoumas J; Prassa ME; Choumerianou DM; Stefanadis C; Humphries SE; Toutouzas P
    Clin Genet; 2003 Nov; 64(5):414-9. PubMed ID: 14616764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
    Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.